Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Completed

Conditions studied: Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Healthy

In brief

This study is conducted in the United States of America (USA). The aim of this study is to assess longitudinal variation of immune biomarkers in subjects with type 1 diabetes (T1D), type 2 diabetes (T2D) and healthy, non-diabetic subjects over a one year period.

Key facts

Study ID

NCT01900834

Run by

Novo Nordisk A/S

People needed

61

Starts

2013-07-01

Expected to finish

2015-10-01

Last updated by the study team

2016-10-10

Who can join

Age: 14 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• T1D
• Male or female subjects diagnosed within the last 3 years and with good general health based on medical history
• Age above or equal to 14 years and below or equal to 40 years
• Body weight above 45 kg
• T2D
• Male or female subjects diagnosed within the last 15 years with good general health based on medical history
• HbA1c between 6.5% and 10%
• Body mass index (BMI) below 45 kg/m\^2
• Age above or equal to 18 and below 65 years
• On insulin treatment
• HS
• Male or female subjects with good general heath based on medical history
• Age above or equal to 18 years and below or equal to 40 years

You may not qualify if…

• Any chronic disorder (besides T1D or T2D) or severe disease which, in the opinion of the investigator, might jeopardize subject's safety or compliance with the protocol
• Female of child-bearing potential who is pregnant, breast-feeding, or intends to become pregnant

Where it is running

• Novo Nordisk Investigational Site — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.